American College of Clinical Pharmacy
      Search      Cart
         

CardSAP 2025


Format to Purchase:
Member Price:
$88.00
Nonmember Price:
$132.00
ASHP members, please call (913)492-3311 to receive multi-book discounts at the member rate. Your ASHP membership number and expiration date are required.

For 2025, the Cardiology Self-Assessment Program (CardSAP) presents a collection of evidence-based updates that are essential for clinicians who aim to stay at the forefront of cardiovascular pharmacotherapy and the delivery of personalized, patient-centered care. The target audience for CardSAP 2025 is board-certified cardiology pharmacy specialists and advanced practitioners specializing in cardiovascular care.

Faculty Panel Chair Ian B. Hollis, Pharm.D., FCCP, BCPS
Hollis

The 2025 CardSAP release comprises 10 learning activities offering a total of 20.5 available continuing pharmacy education (CPE) credits. Each activity may be taken separately for BCCP credits; November 17, 2026, is the deadline to submit a required post-test for recertification. The book was developed under the leadership of Faculty Panel Chair Ian B. Hollis, Pharm.D., FCCP, BCCP, BCPS, Associate Professor, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina.

CardSAP content explores emerging and complex topics such as transthyretin amyloidosis, iron deficiency in heart failure, and HF medication management in patients with continuous-flow LVADs, while also addressing underrecognized conditions like cardiac sarcoidosis and microvascular CVD/MINOCA/ANOCA. It highlights the evolving role of GLP-1 receptor agonists in HFpEF and cardiovascular disease, and integrates contemporary themes such as artificial intelligence and advanced statistical methods like the win ratio in heart failure research. Two case series—Mental Health and Pain Management in CVD and Cardiovascular-Kidney-Metabolic Health—offer practical, interdisciplinary insights for managing comorbidities in special populations.

Each CardSAP release has continuing education activities that cover the most recent published data (past 3–5 years) on a specific therapeutic area or patient-care problem. This content is provided as a full-color electronic book (interactive PDF) with high-level updates in up to three possible formats as best suits the topic delivery:

  • Traditional review-style chapters
  • Case series (a feature that has major sections of learning content bookended by a sample case and its explained answer)
  • Recorded webcast (a PowerPoint presentation provided as an MP4 file as well as a PDF of slides and transcribed narrative)

Every CardSAP release comes in two full-color online formats: (1) interactive PDFs you can save to your desktop or print; and (2) an e-media version you can view on an e-reader, tablet, iOS or Android smart phone.

CardSAP chapters and features are fully referenced, with clickable hyperlinks to literature compilers such as PubMed. Other links provide ready access to clinical practice guidelines, official recommendations, and patient assessment tools. Graphics focus on pivotal studies, patient care scenarios, and take-home points that can be readily integrated into clinical practice.

Release Date: November 17, 2025
BCCP Deadline: November 17, 2026
ACPE Deadline: November 17, 2028

Editor(s): Jackevicius CA, Patterson JH
ISBN: 978-1-964074-29-0
Publication Year: 2025
Format: PDF and ePub

Contents

Chapter: Transthyretin-Related Amyloidosis

This comprehensive learning activity on transthyretin-related amyloidosis (ATTR) is designed to equip clinical pharmacists to improve diagnostic accuracy, optimize heart failure management, and apply ATTR-specific therapies to enhance patient outcomes. Content centers on emerging treatments, management of polyneuropathy, and how to address cost-effectiveness challenges.

Chapter: Iron Deficiency in Heart Failure

This chapter covers the latest evidence-based strategies for identifying and treating iron deficiency in heart failure (IDHF). Learners can explore updated diagnostic criteria, compare intravenous iron formulations such as ferric carboxymaltose and ferric derisomaltose, and design patient-centered repletion regimens to improve functional status, quality of life, and clinical outcomes.

Chapter: Continuous-Flow Left Ventricular Assist Device

This chapter centers around the optimization of HF pharmacotherapy for patients with continuous-flow left ventricular assist devices (CF-LVADs). Explore the evolving role of guideline-directed medical therapy (GDMT) in promoting myocardial recovery, managing LVAD-related complications, and improving long-term outcomes. Topics include RAAS inhibitors, SGLT2 inhibitors, β-blockers, and MRAs, with emphasis on hemodynamic monitoring, device performance, and individualized care.

Chapter: Cardiac Sarcoidosis

This activity explores the complex management of cardiac sarcoidosis (CS) through evidence-based strategies. Content covers diagnostic criteria, imaging modalities, and treatment approaches such as immunosuppressive therapy, steroid-sparing agents, and guideline-directed medical therapy (GDMT) for heart failure and arrhythmias. Emphasis is placed on clinical decision-making to optimize patient outcomes and quality of life.

Chapter: Glucagon-Like Peptide-1 Receptor Agonists in CVD and HFpEF

This activity explores the expanding role of GLP-1 receptor agonists (GLP-1 RAs) in managing cardiovascular disease (CVD) and heart failure with preserved ejection fraction (HFpEF). The content evaluates current evidence supporting GLP-1 RAs for CV risk reduction, weight management, and HF symptom improvement, while addressing prescribing barriers and patient access. The information will assist the clinician by enhancing decision-making and improving patient outcomes in cardiometabolic care.

Chapter: Microvascular CVD/MINOCA/ANOCA

This comprehensive review of microvascular cardiovascular disease focuses on angina with nonobstructive coronary arteries (ANOCA) and myocardial infarction with nonobstructive coronary arteries (MINOCA). Content explores diagnostic strategies, invasive and noninvasive testing, and evidence-based pharmacologic and lifestyle interventions tailored to specific patient endotypes. Emphasis is placed on improving clinical decision-making, quality of life, and cardiovascular outcomes.

Case Series: Mental Health and Pain Management in Patients with CVD

Content of this case-centered feature focuses on the complex interplay between mental health, chronic pain, and cardiovascular disease (CVD). Learners will explore evidence-based pharmacologic and nonpharmacologic strategies for treating depression, anxiety, insomnia, ADHD, and chronic pain in patients with CVD, while optimizing safety, adherence, and quality of life. Special focus is given to palliative pharmacotherapy and deprescribing in end-stage CVD.

Case Series: Cardiovascular-Kidney-Metabolic Health

This activity explores the newly defined cardiovascular-kidney-metabolic (CKM) syndrome, emphasizing its staging, risk factors, and evidence-based treatment strategies. Clinical pharmacists will learn to apply the AHA PREVENT risk calculator, address social determinants of health (SDOH), and optimize pharmacotherapy using agents such as GLP-1 receptor agonists, SGLT2 inhibitors, finerenone, and PCSK9 inhibitors. Designed to enhance decision-making and interdisciplinary collaboration, this activity supports improved outcomes in patients with a composite of CVD, CKD, T2D, and obesity.

Chapter: Artificial Intelligence in the Management of CVD

This activity explores the transformative role of artificial intelligence (AI) in cardiovascular disease (CVD) management, with a focus on clinical applications for pharmacists. Learners will examine AI-driven tools for risk prediction, phenotyping, remote monitoring, and decision support in areas such as anticoagulation, heart failure, cardio-oncology, and QTc monitoring. The chapter also addresses ethical, legal, and practical challenges of AI integration in pharmacy practice.

Chapter: Statistics Applied to Heart Failure Studies: Win Ratio

This chapter introduces clinical pharmacists to the win ratio (WR)—a novel statistical method for analyzing composite outcomes in heart failure (HF) trials. Learners will compare WR to conventional approaches, evaluate its application in landmark studies (e.g., PARAGON-HF, VICTORIA, EMPULSE), and explore its effect on interpreting treatment efficacy. Emphasis is placed on enhancing evidence-based decision-making and optimizing patient outcomes.

Chapter: Glucagon-Like Peptide-1 Receptor Agonists in CVD and HFpEF

Faculty

Anne Rodino, Pharm.D., BCCP
Cardiology Clinical Pharmacist Practitioner
Department of Pharmacy
UNC Hospitals and Clinics
Chapel Hill, North Carolina
Holly McIlvain, Pharm.D., BCACP, CSP
Consultant
Visante
Chicago, Illinois

Reviewers

Sheila L. Stadler, Pharm.D., FCCP, BCPS, CLS
Clinical Pharmacy Specialist
Clinical Pharmacy Cardiac Risk Service
Kaiser Permanente Colorado
Aurora, Colorado
Elizabeth Tesch, Pharm.D., BCPS, BCCP
Pharmacy Flight Commander
42d Healthcare Operations Squadron
United States Air Force
Maxwell Air Force Base, Alabama
Emily McElhaney, Pharm.D., BCCP
Cardiology Clinical Pharmacy Specialist
Department of Pharmacy
Cleveland Clinic
Cleveland, Ohio

Chapter: Microvascular CVD/MINOCA/ANOCA

Faculty

Charles H. Hayes, III, Pharm.D., FACC, BCCP
Cardiology Clinical Pharmacist
Department of Pharmacy
Saint Luke’s Hospital of Kansas City
Kansas City, Missouri
John Dechand, Pharm.D., BCCP
Cardiovascular Clinical Pharmacist
Team Lead – Cardiovascular Medicine Pharmacists
Department of Pharmacy Services
University of Utah Health
Salt Lake City, Utah

Reviewers

Steven P. Dunn, Pharm.D., FAHA, FCCP, BCCP
Lead Pharmacist, Heart & Vascular
University of Virginia
Charlottesville, Virginia
Jordan L. Lacoste, Pharm.D., FACC, BCCP
Clinical Pharmacy Specialist
Department of Pharmacy
WVU Medicine
Morgantown, West Virginia
Matthew Rockhold, Pharm.D., BCCP
Cardiac Surgery Pharmacist
Department of Pharmacy
West Virginia University Medicine
Morgantown, West Virginia

Chapter: Continuous-Flow Left Ventricular Assist Device

Faculty

Erika M. Schoenborn, Pharm.D., BCCP
Clinical Pharmacist Practitioner
Department of Pharmacy
East Carolina University Health
Greenville, North Carolina

Reviewers

Edward T. Horn, Pharm.D., FCCP
Associate Professor
Department of Pharmacy and Therapeutics
University of Pittsburgh School of Pharmacy
Pittsburgh, Pennsylvania
Lauren Kunkel, Pharm.D., BCCP
Cardiology Clinical Pharmacy Specialist
Department of Pharmacy
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
Julie Clarkson, Pharm.D., BCCCP, BCCP, BCPS
Assistant Professor
University of Pittsburgh School of Pharmacy
Clinical Pharmacist, Advanced Heart Failure and Pulmonary Hypertension
UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania

Case Series: Mental Health and Pain Management in Patients with CVD

Faculty

Katherine E. Di Palo, Pharm.D., MBA, MS, FAHA, FHFSA, BCACP, BCGP
Senior Director
Transitional Care Excellence
Associate Professor
Department of Medicine
Montefiore medical Center
The University Hospital for Albert Einstein College of Medicine
Bronx, New York

Reviewers

M. Lindsey Hedgepeth Kennedy, Pharm.D., BCPS
Clinical specialist in Psychiatry & Addiction Medicine
UNC Health
Clinical Assistant Professor
Addiction Medicine Program
Department of Psychiatry
UNC School of Medicine
Chapel Hill, North Carolina
Rachel C. Lucas, Pharm.D., BCCP
Clinical Assistant Professor
Department of Pharmacy Practice
Binghamton University School of Pharmacy and Pharmaceutical Sciences
Binghamton, New York

Chapter: Artificial Intelligence in the Management of CVD

Faculty

Kazuhiko Kido, Pharm.D., Ph.D., FCCP, BCPS, BCCP
Clinical Associate Professor
Department of Clinical Pharmacy
West Virginia University School of Pharmacy
Morgantown, West Virginia
James C. Lee, Pharm.D., FCCP, AACC, BCACP
Clinical Pharmacist Practitioner
Michael E. DeBakey VA Medical Center
Houston, TX

Reviewers

Hsiang-Yin Chen, Pharm.D.
Professor and Vice Dean
Department of Clinical Pharmacy
School of Pharmacy
Taipei Medical University
Taipei, Taiwan
Dustin Spencer, Pharm.D., MBA, FCCP, BCCP, BCPS
Clinical Director, Cardiopulmonary Diseases
Cardinal Health
Stafford, Texas
Adrian Wong, Pharm.D., MPH, FCCM, FCCP, BCCCP
Clinical Pharmacy Specialist, Medical ICU
Department of Pharmacy
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Chapter: Transthyretin-Related Amyloidosis

Faculty

Lauren Kemp, Pharm.D., BCCP, BCPS, CPP
Clinical Pharmacist
Advanced Heart Failure Clinic
Cone Health/Moses H. Cone Memorial Hospital
Greensboro, North Carolina
Arwa Omary, Pharm.D., BCCP
Cardiology Clinical Pharmacy Specialist
Intensive Care Unit
Prairie Mountain Health
Manitoba, Canada

Reviewers

Kathleen Faulkenberg, Pharm.D., FHFSA, BCCP
Associate Director of Cardiology, Transplant, and Transitions of Care
Department of Pharmacy
University of Kentucky Healthcare
Lexington, Kentucky
Amy Hathorn, Pharm.D., BCCP
Clinical Pharmacist Specialist
Department of Pharmacy
Atrium Health
Charlotte, North Carolina
Tomasz Jurga, Pharm.D., BCPS, BCACP, BCCP, CDCES
Clinical Pharmacist Practitioner, Cardiology
Department of Pharmacy
Lieutenant Colonel Charles S. Kettles VA Medical Center
Ann Arbor, Michigan

Chapter: Cardiac Sarcoidosis

Faculty

Megan Clarke, Pharm.D., BCCP
Clinical Pharmacist Practitioner - Cardiology
Department of Cardiology
Novant Health Heart & Vascular Institute
Wilmington, North Carolina
Adele L. Rawls, Pharm.D., BCPS
Assistant Professor for Pharmacology
Edward Via College of Osteopathic Medicine
Spartanburg, South Carolina

Reviewers

James C. Coons, Pharm.D., FCCP, FACC, BCCP
Professor
Department of Pharmacy and Therapeutics
University of Pittsburgh
Clinical Pharmacist, Cardiology
UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania
Kristen de Almeida, MSc, Pharm.D., BCCP, HF-CERT
Cardiology Pharmacy Coordinator
Advanced Heart failure Specialist
Baptist Hospital of Miami
Miami, Florida
Sabrina Dunham, Pharm.D., BCCP, BCPS
Clinical Pharmacist Specialist – Cardiovascular Critical Care
Department of Pharmacy Services
University of Michigan Health
Ann Arbor, Michigan

Case Series: Cardiovascular-Kidney-Metabolic Health

Faculty

Rebecca JC Tran, Pharm.D., BCPS, BCACP, BCCP, CLS
Associate Professor
Department of Pharmacy Practice and Administration
Western University of Health Sciences College of Pharmacy
Pomona, California
Sheryl L. Chow, Pharm.D., FCCP, FAHA, FHFSA
Professor
Department of Pharmacy Practice and Administration
Western University of Health Sciences College of Pharmacy
Pomona, California

Reviewers

Robert L. Page, II, Pharm.D., MSPH, FCCP, FASHP, FASCP, FAHA, FHFSA, BCPS
Professor
Departments of Clinical Pharmacy, Medicine, and Physical Medicine
University of Colorado
Aurora, Colorado
Lavinia Salama, Pharm.D., BCACP, BCGP, BC-ADM, CDCES
Assistant Professor of Pharmacy Practice
Long Island University
Arnold & Marie Schwartz College of Pharmacy and Health Sciences
Brooklyn, New York
Kathy Tang, Pharm.D., BCCP
Clinical Pharmacy Specialist, Cardiology
Department of Pharmacy
Wellstar Kennestone Regional Medical Center
Marietta, Georgia

Chapter: Iron Deficiency in Heart Failure

Faculty

Sarah Wood, Pharm.D.
Cardiology Clinical Pharmacist
Department of Pharmacy
Atrium Health Carolinas Medical Center
Charlotte, North Carolina
Stormi Gale, Pharm.D., FCCP, BCPS, BCCP
Cardiology Pharmacy Coordinator
Department of Pharmacy
Atrium Health Carolinas Medical Center
Charlotte, North Carolina

Reviewers

John E. MacKay, Pharm.D.
Clinical Pharmacy Specialist, Advanced Heart Failure and Heart Transplant
Department of Pharmacy
Providence Heart Institute of Oregon
Providence St. Vincent Medical Center
Portland, Oregon
Melanie R. Madorsky, Pharm.D., BCCCP, BCCP, BCPS
Clinical Pharmacy Specialist, Cardiac Care Unit
Department of Pharmacy
Memorial Hermann-Texas Medical Center
Houston, Texas
Mallory T. Mouradjian, Pharm.D., BCCP
Clinical Pharmacy Specialist
Department of Pharmacy
Boston Medical Center
Boston, Massachusetts

Chapter: Statistics Applied to Heart Failure Studies: Win Ratio

Faculty

William L. Baker, Pharm.D., FCCP, FACC, FHFSA
Professor
Department of Pharmacy Practice
University of Connecticut School of Pharmacy
Storrs, Connecticut
Youssef Bessada, Pharm.D., BCPS, BCCP
Assistant Clinical Professor
Department of Pharmacy Practice
University of Connecticut School of Pharmacy
Storrs, Connecticut
Katelyn Galli, Pharm.D., BCCP
Clinical Assistant Professor
Department of Pharmacy Practice
University of Connecticut School of Pharmacy
Storrs, Connecticut

Reviewers

Catherine G. Derington, Pharm.D., MS, BCACP
Assistant Professor
Department of Medicine, Division of Cardiology
University of Colorado School of Medicine, Anschutz Medical Campus
Aurora, Colorado
Brian A. Lopez, Pharm.D., BCCP, BCCCP
Clinical Pharmacist
Department of Pharmacy
New London Hospital
New London, New Hampshire
Carol Heunisch, Pharm.D., BCPS, BCCP
Director, Drug Policy and Education
Department of Pharmacy
Endeavor Health
Evanston, Illinois

Chapter: Cardiac Sarcoidosis

Faculty

Megan Clarke, Pharm.D., BCCP
Clinical Pharmacist Practitioner - Cardiology
Department of Cardiology
Novant Health Heart & Vascular Institute
Wilmington, North Carolina
Adele L. Rawls, Pharm.D., BCPS
Assistant Professor for Pharmacology
Edward Via College of Osteopathic Medicine
Spartanburg, South Carolina

Reviewers

James C. Coons, Pharm.D., FCCP, FACC, BCCP
Professor
Department of Pharmacy and Therapeutics
University of Pittsburgh
Clinical Pharmacist, Cardiology
UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania
Kristen de Almeida, MSc, Pharm.D., BCCP, HF-CERT
Cardiology Pharmacy Coordinator
Advanced Heart failure Specialist
Baptist Hospital of Miami
Miami, Florida
Sabrina Dunham, Pharm.D., BCCP, BCPS
Clinical Pharmacist Specialist – Cardiovascular Critical Care
Department of Pharmacy Services
University of Michigan Health
Ann Arbor, Michigan

Chapter: Transthyretin-Related Amyloidosis

Faculty

Lauren Kemp, Pharm.D., BCCP, BCPS, CPP
Clinical Pharmacist
Advanced Heart Failure Clinic
Cone Health/Moses H. Cone Memorial Hospital
Greensboro, North Carolina
Arwa Omary, Pharm.D., BCCP
Cardiology Clinical Pharmacy Specialist
Intensive Care Unit
Prairie Mountain Health
Manitoba, Canada

Reviewers

Kathleen Faulkenberg, Pharm.D., FHFSA, BCCP
Associate Director of Cardiology, Transplant, and Transitions of Care
Department of Pharmacy
University of Kentucky Healthcare
Lexington, Kentucky
Amy Hathorn, Pharm.D., BCCP
Clinical Pharmacist Specialist
Department of Pharmacy
Atrium Health
Charlotte, North Carolina
Tomasz Jurga, Pharm.D., BCPS, BCACP, BCCP, CDCES
Clinical Pharmacist Practitioner, Cardiology
Department of Pharmacy
Lieutenant Colonel Charles S. Kettles VA Medical Center
Ann Arbor, Michigan

Chapter: Glucagon-Like Peptide-1 Receptor Agonists in CVD and HFpEF

Faculty

Anne Rodino, Pharm.D., BCCP
Cardiology Clinical Pharmacist Practitioner
Department of Pharmacy
UNC Hospitals and Clinics
Chapel Hill, North Carolina
Holly McIlvain, Pharm.D., BCACP, CSP
Consultant
Visante
Chicago, Illinois

Reviewers

Sheila L. Stadler, Pharm.D., FCCP, BCPS, CLS
Clinical Pharmacy Specialist
Clinical Pharmacy Cardiac Risk Service
Kaiser Permanente Colorado
Aurora, Colorado
Elizabeth Tesch, Pharm.D., BCPS, BCCP
Pharmacy Flight Commander
42d Healthcare Operations Squadron
United States Air Force
Maxwell Air Force Base, Alabama
Emily McElhaney, Pharm.D., BCCP
Cardiology Clinical Pharmacy Specialist
Department of Pharmacy
Cleveland Clinic
Cleveland, Ohio

Chapter: Artificial Intelligence in the Management of CVD

Faculty

Kazuhiko Kido, Pharm.D., Ph.D., FCCP, BCPS, BCCP
Clinical Associate Professor
Department of Clinical Pharmacy
West Virginia University School of Pharmacy
Morgantown, West Virginia
James C. Lee, Pharm.D., FCCP, AACC, BCACP
Clinical Pharmacist Practitioner
Michael E. DeBakey VA Medical Center
Houston, TX

Reviewers

Hsiang-Yin Chen, Pharm.D.
Professor and Vice Dean
Department of Clinical Pharmacy
School of Pharmacy
Taipei Medical University
Taipei, Taiwan
Dustin Spencer, Pharm.D., MBA, FCCP, BCCP, BCPS
Clinical Director, Cardiopulmonary Diseases
Cardinal Health
Stafford, Texas
Adrian Wong, Pharm.D., MPH, FCCM, FCCP, BCCCP
Clinical Pharmacy Specialist, Medical ICU
Department of Pharmacy
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Chapter: Microvascular CVD/MINOCA/ANOCA

Faculty

Charles H. Hayes, III, Pharm.D., FACC, BCCP
Cardiology Clinical Pharmacist
Department of Pharmacy
Saint Luke’s Hospital of Kansas City
Kansas City, Missouri
John Dechand, Pharm.D., BCCP
Cardiovascular Clinical Pharmacist
Team Lead – Cardiovascular Medicine Pharmacists
Department of Pharmacy Services
University of Utah Health
Salt Lake City, Utah

Reviewers

Steven P. Dunn, Pharm.D., FAHA, FCCP, BCCP
Lead Pharmacist, Heart & Vascular
University of Virginia
Charlottesville, Virginia
Jordan L. Lacoste, Pharm.D., FACC, BCCP
Clinical Pharmacy Specialist
Department of Pharmacy
WVU Medicine
Morgantown, West Virginia
Matthew Rockhold, Pharm.D., BCCP
Cardiac Surgery Pharmacist
Department of Pharmacy
West Virginia University Medicine
Morgantown, West Virginia

Case Series: Cardiovascular-Kidney-Metabolic Health

Faculty

Rebecca JC Tran, Pharm.D., BCPS, BCACP, BCCP, CLS
Associate Professor
Department of Pharmacy Practice and Administration
Western University of Health Sciences College of Pharmacy
Pomona, California
Sheryl L. Chow, Pharm.D., FCCP, FAHA, FHFSA
Professor
Department of Pharmacy Practice and Administration
Western University of Health Sciences College of Pharmacy
Pomona, California

Reviewers

Robert L. Page, II, Pharm.D., MSPH, FCCP, FASHP, FASCP, FAHA, FHFSA, BCPS
Professor
Departments of Clinical Pharmacy, Medicine, and Physical Medicine
University of Colorado
Aurora, Colorado
Lavinia Salama, Pharm.D., BCACP, BCGP, BC-ADM, CDCES
Assistant Professor of Pharmacy Practice
Long Island University
Arnold & Marie Schwartz College of Pharmacy and Health Sciences
Brooklyn, New York
Kathy Tang, Pharm.D., BCCP
Clinical Pharmacy Specialist, Cardiology
Department of Pharmacy
Wellstar Kennestone Regional Medical Center
Marietta, Georgia

Chapter: Iron Deficiency in Heart Failure

Faculty

Sarah Wood, Pharm.D.
Cardiology Clinical Pharmacist
Department of Pharmacy
Atrium Health Carolinas Medical Center
Charlotte, North Carolina
Stormi Gale, Pharm.D., FCCP, BCPS, BCCP
Cardiology Pharmacy Coordinator
Department of Pharmacy
Atrium Health Carolinas Medical Center
Charlotte, North Carolina

Reviewers

John E. MacKay, Pharm.D.
Clinical Pharmacy Specialist, Advanced Heart Failure and Heart Transplant
Department of Pharmacy
Providence Heart Institute of Oregon
Providence St. Vincent Medical Center
Portland, Oregon
Melanie R. Madorsky, Pharm.D., BCCCP, BCCP, BCPS
Clinical Pharmacy Specialist, Cardiac Care Unit
Department of Pharmacy
Memorial Hermann-Texas Medical Center
Houston, Texas
Mallory T. Mouradjian, Pharm.D., BCCP
Clinical Pharmacy Specialist
Department of Pharmacy
Boston Medical Center
Boston, Massachusetts

Chapter: Statistics Applied to Heart Failure Studies: Win Ratio

Faculty

William L. Baker, Pharm.D., FCCP, FACC, FHFSA
Professor
Department of Pharmacy Practice
University of Connecticut School of Pharmacy
Storrs, Connecticut
Youssef Bessada, Pharm.D., BCPS, BCCP
Assistant Clinical Professor
Department of Pharmacy Practice
University of Connecticut School of Pharmacy
Storrs, Connecticut
Katelyn Galli, Pharm.D., BCCP
Clinical Assistant Professor
Department of Pharmacy Practice
University of Connecticut School of Pharmacy
Storrs, Connecticut

Reviewers

Catherine G. Derington, Pharm.D., MS, BCACP
Assistant Professor
Department of Medicine, Division of Cardiology
University of Colorado School of Medicine, Anschutz Medical Campus
Aurora, Colorado
Brian A. Lopez, Pharm.D., BCCP, BCCCP
Clinical Pharmacist
Department of Pharmacy
New London Hospital
New London, New Hampshire
Carol Heunisch, Pharm.D., BCPS, BCCP
Director, Drug Policy and Education
Department of Pharmacy
Endeavor Health
Evanston, Illinois

Chapter: Continuous-Flow Left Ventricular Assist Device

Faculty

Erika M. Schoenborn, Pharm.D., BCCP
Clinical Pharmacist Practitioner
Department of Pharmacy
East Carolina University Health
Greenville, North Carolina

Reviewers

Edward T. Horn, Pharm.D., FCCP
Associate Professor
Department of Pharmacy and Therapeutics
University of Pittsburgh School of Pharmacy
Pittsburgh, Pennsylvania
Lauren Kunkel, Pharm.D., BCCP
Cardiology Clinical Pharmacy Specialist
Department of Pharmacy
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
Julie Clarkson, Pharm.D., BCCCP, BCCP, BCPS
Assistant Professor
University of Pittsburgh School of Pharmacy
Clinical Pharmacist, Advanced Heart Failure and Pulmonary Hypertension
UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania

Chapter: Artificial Intelligence in the Management of CVD

Faculty

Kazuhiko Kido, Pharm.D., Ph.D., FCCP, BCPS, BCCP
Clinical Associate Professor
Department of Clinical Pharmacy
West Virginia University School of Pharmacy
Morgantown, West Virginia
James C. Lee, Pharm.D., FCCP, AACC, BCACP
Clinical Pharmacist Practitioner
Michael E. DeBakey VA Medical Center
Houston, TX

Reviewers

Hsiang-Yin Chen, Pharm.D.
Professor and Vice Dean
Department of Clinical Pharmacy
School of Pharmacy
Taipei Medical University
Taipei, Taiwan
Dustin Spencer, Pharm.D., MBA, FCCP, BCCP, BCPS
Clinical Director, Cardiopulmonary Diseases
Cardinal Health
Stafford, Texas
Adrian Wong, Pharm.D., MPH, FCCM, FCCP, BCCCP
Clinical Pharmacy Specialist, Medical ICU
Department of Pharmacy
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Chapter: Cardiac Sarcoidosis

Faculty

Megan Clarke, Pharm.D., BCCP
Clinical Pharmacist Practitioner - Cardiology
Department of Cardiology
Novant Health Heart & Vascular Institute
Wilmington, North Carolina
Adele L. Rawls, Pharm.D., BCPS
Assistant Professor for Pharmacology
Edward Via College of Osteopathic Medicine
Spartanburg, South Carolina

Reviewers

James C. Coons, Pharm.D., FCCP, FACC, BCCP
Professor
Department of Pharmacy and Therapeutics
University of Pittsburgh
Clinical Pharmacist, Cardiology
UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania
Kristen de Almeida, MSc, Pharm.D., BCCP, HF-CERT
Cardiology Pharmacy Coordinator
Advanced Heart failure Specialist
Baptist Hospital of Miami
Miami, Florida
Sabrina Dunham, Pharm.D., BCCP, BCPS
Clinical Pharmacist Specialist – Cardiovascular Critical Care
Department of Pharmacy Services
University of Michigan Health
Ann Arbor, Michigan

Chapter: Iron Deficiency in Heart Failure

Faculty

Sarah Wood, Pharm.D.
Cardiology Clinical Pharmacist
Department of Pharmacy
Atrium Health Carolinas Medical Center
Charlotte, North Carolina
Stormi Gale, Pharm.D., FCCP, BCPS, BCCP
Cardiology Pharmacy Coordinator
Department of Pharmacy
Atrium Health Carolinas Medical Center
Charlotte, North Carolina

Reviewers

John E. MacKay, Pharm.D.
Clinical Pharmacy Specialist, Advanced Heart Failure and Heart Transplant
Department of Pharmacy
Providence Heart Institute of Oregon
Providence St. Vincent Medical Center
Portland, Oregon
Melanie R. Madorsky, Pharm.D., BCCCP, BCCP, BCPS
Clinical Pharmacy Specialist, Cardiac Care Unit
Department of Pharmacy
Memorial Hermann-Texas Medical Center
Houston, Texas
Mallory T. Mouradjian, Pharm.D., BCCP
Clinical Pharmacy Specialist
Department of Pharmacy
Boston Medical Center
Boston, Massachusetts

Chapter: Transthyretin-Related Amyloidosis

Faculty

Lauren Kemp, Pharm.D., BCCP, BCPS, CPP
Clinical Pharmacist
Advanced Heart Failure Clinic
Cone Health/Moses H. Cone Memorial Hospital
Greensboro, North Carolina
Arwa Omary, Pharm.D., BCCP
Cardiology Clinical Pharmacy Specialist
Intensive Care Unit
Prairie Mountain Health
Manitoba, Canada

Reviewers

Kathleen Faulkenberg, Pharm.D., FHFSA, BCCP
Associate Director of Cardiology, Transplant, and Transitions of Care
Department of Pharmacy
University of Kentucky Healthcare
Lexington, Kentucky
Amy Hathorn, Pharm.D., BCCP
Clinical Pharmacist Specialist
Department of Pharmacy
Atrium Health
Charlotte, North Carolina
Tomasz Jurga, Pharm.D., BCPS, BCACP, BCCP, CDCES
Clinical Pharmacist Practitioner, Cardiology
Department of Pharmacy
Lieutenant Colonel Charles S. Kettles VA Medical Center
Ann Arbor, Michigan

Case Series: Mental Health and Pain Management in Patients with CVD

Faculty

Katherine E. Di Palo, Pharm.D., MBA, MS, FAHA, FHFSA, BCACP, BCGP
Senior Director
Transitional Care Excellence
Associate Professor
Department of Medicine
Montefiore medical Center
The University Hospital for Albert Einstein College of Medicine
Bronx, New York

Reviewers

M. Lindsey Hedgepeth Kennedy, Pharm.D., BCPS
Clinical specialist in Psychiatry & Addiction Medicine
UNC Health
Clinical Assistant Professor
Addiction Medicine Program
Department of Psychiatry
UNC School of Medicine
Chapel Hill, North Carolina
Rachel C. Lucas, Pharm.D., BCCP
Clinical Assistant Professor
Department of Pharmacy Practice
Binghamton University School of Pharmacy and Pharmaceutical Sciences
Binghamton, New York

Case Series: Cardiovascular-Kidney-Metabolic Health

Faculty

Rebecca JC Tran, Pharm.D., BCPS, BCACP, BCCP, CLS
Associate Professor
Department of Pharmacy Practice and Administration
Western University of Health Sciences College of Pharmacy
Pomona, California
Sheryl L. Chow, Pharm.D., FCCP, FAHA, FHFSA
Professor
Department of Pharmacy Practice and Administration
Western University of Health Sciences College of Pharmacy
Pomona, California

Reviewers

Robert L. Page, II, Pharm.D., MSPH, FCCP, FASHP, FASCP, FAHA, FHFSA, BCPS
Professor
Departments of Clinical Pharmacy, Medicine, and Physical Medicine
University of Colorado
Aurora, Colorado
Lavinia Salama, Pharm.D., BCACP, BCGP, BC-ADM, CDCES
Assistant Professor of Pharmacy Practice
Long Island University
Arnold & Marie Schwartz College of Pharmacy and Health Sciences
Brooklyn, New York
Kathy Tang, Pharm.D., BCCP
Clinical Pharmacy Specialist, Cardiology
Department of Pharmacy
Wellstar Kennestone Regional Medical Center
Marietta, Georgia

Chapter: Glucagon-Like Peptide-1 Receptor Agonists in CVD and HFpEF

Faculty

Anne Rodino, Pharm.D., BCCP
Cardiology Clinical Pharmacist Practitioner
Department of Pharmacy
UNC Hospitals and Clinics
Chapel Hill, North Carolina
Holly McIlvain, Pharm.D., BCACP, CSP
Consultant
Visante
Chicago, Illinois

Reviewers

Sheila L. Stadler, Pharm.D., FCCP, BCPS, CLS
Clinical Pharmacy Specialist
Clinical Pharmacy Cardiac Risk Service
Kaiser Permanente Colorado
Aurora, Colorado
Elizabeth Tesch, Pharm.D., BCPS, BCCP
Pharmacy Flight Commander
42d Healthcare Operations Squadron
United States Air Force
Maxwell Air Force Base, Alabama
Emily McElhaney, Pharm.D., BCCP
Cardiology Clinical Pharmacy Specialist
Department of Pharmacy
Cleveland Clinic
Cleveland, Ohio

Chapter: Microvascular CVD/MINOCA/ANOCA

Faculty

Charles H. Hayes, III, Pharm.D., FACC, BCCP
Cardiology Clinical Pharmacist
Department of Pharmacy
Saint Luke’s Hospital of Kansas City
Kansas City, Missouri
John Dechand, Pharm.D., BCCP
Cardiovascular Clinical Pharmacist
Team Lead – Cardiovascular Medicine Pharmacists
Department of Pharmacy Services
University of Utah Health
Salt Lake City, Utah

Reviewers

Steven P. Dunn, Pharm.D., FAHA, FCCP, BCCP
Lead Pharmacist, Heart & Vascular
University of Virginia
Charlottesville, Virginia
Jordan L. Lacoste, Pharm.D., FACC, BCCP
Clinical Pharmacy Specialist
Department of Pharmacy
WVU Medicine
Morgantown, West Virginia
Matthew Rockhold, Pharm.D., BCCP
Cardiac Surgery Pharmacist
Department of Pharmacy
West Virginia University Medicine
Morgantown, West Virginia

Chapter: Transthyretin-Related Amyloidosis

Faculty

Lauren Kemp, Pharm.D., BCCP, BCPS, CPP
Clinical Pharmacist
Advanced Heart Failure Clinic
Cone Health/Moses H. Cone Memorial Hospital
Greensboro, North Carolina
Arwa Omary, Pharm.D., BCCP
Cardiology Clinical Pharmacy Specialist
Intensive Care Unit
Prairie Mountain Health
Manitoba, Canada

Reviewers

Kathleen Faulkenberg, Pharm.D., FHFSA, BCCP
Associate Director of Cardiology, Transplant, and Transitions of Care
Department of Pharmacy
University of Kentucky Healthcare
Lexington, Kentucky
Amy Hathorn, Pharm.D., BCCP
Clinical Pharmacist Specialist
Department of Pharmacy
Atrium Health
Charlotte, North Carolina
Tomasz Jurga, Pharm.D., BCPS, BCACP, BCCP, CDCES
Clinical Pharmacist Practitioner, Cardiology
Department of Pharmacy
Lieutenant Colonel Charles S. Kettles VA Medical Center
Ann Arbor, Michigan

Chapter: Statistics Applied to Heart Failure Studies: Win Ratio

Faculty

William L. Baker, Pharm.D., FCCP, FACC, FHFSA
Professor
Department of Pharmacy Practice
University of Connecticut School of Pharmacy
Storrs, Connecticut
Youssef Bessada, Pharm.D., BCPS, BCCP
Assistant Clinical Professor
Department of Pharmacy Practice
University of Connecticut School of Pharmacy
Storrs, Connecticut
Katelyn Galli, Pharm.D., BCCP
Clinical Assistant Professor
Department of Pharmacy Practice
University of Connecticut School of Pharmacy
Storrs, Connecticut

Reviewers

Catherine G. Derington, Pharm.D., MS, BCACP
Assistant Professor
Department of Medicine, Division of Cardiology
University of Colorado School of Medicine, Anschutz Medical Campus
Aurora, Colorado
Brian A. Lopez, Pharm.D., BCCP, BCCCP
Clinical Pharmacist
Department of Pharmacy
New London Hospital
New London, New Hampshire
Carol Heunisch, Pharm.D., BCPS, BCCP
Director, Drug Policy and Education
Department of Pharmacy
Endeavor Health
Evanston, Illinois

Chapter: Artificial Intelligence in the Management of CVD

Faculty

Kazuhiko Kido, Pharm.D., Ph.D., FCCP, BCPS, BCCP
Clinical Associate Professor
Department of Clinical Pharmacy
West Virginia University School of Pharmacy
Morgantown, West Virginia
James C. Lee, Pharm.D., FCCP, AACC, BCACP
Clinical Pharmacist Practitioner
Michael E. DeBakey VA Medical Center
Houston, TX

Reviewers

Hsiang-Yin Chen, Pharm.D.
Professor and Vice Dean
Department of Clinical Pharmacy
School of Pharmacy
Taipei Medical University
Taipei, Taiwan
Dustin Spencer, Pharm.D., MBA, FCCP, BCCP, BCPS
Clinical Director, Cardiopulmonary Diseases
Cardinal Health
Stafford, Texas
Adrian Wong, Pharm.D., MPH, FCCM, FCCP, BCCCP
Clinical Pharmacy Specialist, Medical ICU
Department of Pharmacy
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Chapter: Glucagon-Like Peptide-1 Receptor Agonists in CVD and HFpEF

Faculty

Anne Rodino, Pharm.D., BCCP
Cardiology Clinical Pharmacist Practitioner
Department of Pharmacy
UNC Hospitals and Clinics
Chapel Hill, North Carolina
Holly McIlvain, Pharm.D., BCACP, CSP
Consultant
Visante
Chicago, Illinois

Reviewers

Sheila L. Stadler, Pharm.D., FCCP, BCPS, CLS
Clinical Pharmacy Specialist
Clinical Pharmacy Cardiac Risk Service
Kaiser Permanente Colorado
Aurora, Colorado
Elizabeth Tesch, Pharm.D., BCPS, BCCP
Pharmacy Flight Commander
42d Healthcare Operations Squadron
United States Air Force
Maxwell Air Force Base, Alabama
Emily McElhaney, Pharm.D., BCCP
Cardiology Clinical Pharmacy Specialist
Department of Pharmacy
Cleveland Clinic
Cleveland, Ohio

Chapter: Microvascular CVD/MINOCA/ANOCA

Faculty

Charles H. Hayes, III, Pharm.D., FACC, BCCP
Cardiology Clinical Pharmacist
Department of Pharmacy
Saint Luke’s Hospital of Kansas City
Kansas City, Missouri
John Dechand, Pharm.D., BCCP
Cardiovascular Clinical Pharmacist
Team Lead – Cardiovascular Medicine Pharmacists
Department of Pharmacy Services
University of Utah Health
Salt Lake City, Utah

Reviewers

Steven P. Dunn, Pharm.D., FAHA, FCCP, BCCP
Lead Pharmacist, Heart & Vascular
University of Virginia
Charlottesville, Virginia
Jordan L. Lacoste, Pharm.D., FACC, BCCP
Clinical Pharmacy Specialist
Department of Pharmacy
WVU Medicine
Morgantown, West Virginia
Matthew Rockhold, Pharm.D., BCCP
Cardiac Surgery Pharmacist
Department of Pharmacy
West Virginia University Medicine
Morgantown, West Virginia

Chapter: Cardiac Sarcoidosis

Faculty

Megan Clarke, Pharm.D., BCCP
Clinical Pharmacist Practitioner - Cardiology
Department of Cardiology
Novant Health Heart & Vascular Institute
Wilmington, North Carolina
Adele L. Rawls, Pharm.D., BCPS
Assistant Professor for Pharmacology
Edward Via College of Osteopathic Medicine
Spartanburg, South Carolina

Reviewers

James C. Coons, Pharm.D., FCCP, FACC, BCCP
Professor
Department of Pharmacy and Therapeutics
University of Pittsburgh
Clinical Pharmacist, Cardiology
UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania
Kristen de Almeida, MSc, Pharm.D., BCCP, HF-CERT
Cardiology Pharmacy Coordinator
Advanced Heart failure Specialist
Baptist Hospital of Miami
Miami, Florida
Sabrina Dunham, Pharm.D., BCCP, BCPS
Clinical Pharmacist Specialist – Cardiovascular Critical Care
Department of Pharmacy Services
University of Michigan Health
Ann Arbor, Michigan

Chapter: Continuous-Flow Left Ventricular Assist Device

Faculty

Erika M. Schoenborn, Pharm.D., BCCP
Clinical Pharmacist Practitioner
Department of Pharmacy
East Carolina University Health
Greenville, North Carolina

Reviewers

Edward T. Horn, Pharm.D., FCCP
Associate Professor
Department of Pharmacy and Therapeutics
University of Pittsburgh School of Pharmacy
Pittsburgh, Pennsylvania
Lauren Kunkel, Pharm.D., BCCP
Cardiology Clinical Pharmacy Specialist
Department of Pharmacy
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
Julie Clarkson, Pharm.D., BCCCP, BCCP, BCPS
Assistant Professor
University of Pittsburgh School of Pharmacy
Clinical Pharmacist, Advanced Heart Failure and Pulmonary Hypertension
UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania

Case Series: Cardiovascular-Kidney-Metabolic Health

Faculty

Rebecca JC Tran, Pharm.D., BCPS, BCACP, BCCP, CLS
Associate Professor
Department of Pharmacy Practice and Administration
Western University of Health Sciences College of Pharmacy
Pomona, California
Sheryl L. Chow, Pharm.D., FCCP, FAHA, FHFSA
Professor
Department of Pharmacy Practice and Administration
Western University of Health Sciences College of Pharmacy
Pomona, California

Reviewers

Robert L. Page, II, Pharm.D., MSPH, FCCP, FASHP, FASCP, FAHA, FHFSA, BCPS
Professor
Departments of Clinical Pharmacy, Medicine, and Physical Medicine
University of Colorado
Aurora, Colorado
Lavinia Salama, Pharm.D., BCACP, BCGP, BC-ADM, CDCES
Assistant Professor of Pharmacy Practice
Long Island University
Arnold & Marie Schwartz College of Pharmacy and Health Sciences
Brooklyn, New York
Kathy Tang, Pharm.D., BCCP
Clinical Pharmacy Specialist, Cardiology
Department of Pharmacy
Wellstar Kennestone Regional Medical Center
Marietta, Georgia

Chapter: Iron Deficiency in Heart Failure

Faculty

Sarah Wood, Pharm.D.
Cardiology Clinical Pharmacist
Department of Pharmacy
Atrium Health Carolinas Medical Center
Charlotte, North Carolina
Stormi Gale, Pharm.D., FCCP, BCPS, BCCP
Cardiology Pharmacy Coordinator
Department of Pharmacy
Atrium Health Carolinas Medical Center
Charlotte, North Carolina

Reviewers

John E. MacKay, Pharm.D.
Clinical Pharmacy Specialist, Advanced Heart Failure and Heart Transplant
Department of Pharmacy
Providence Heart Institute of Oregon
Providence St. Vincent Medical Center
Portland, Oregon
Melanie R. Madorsky, Pharm.D., BCCCP, BCCP, BCPS
Clinical Pharmacy Specialist, Cardiac Care Unit
Department of Pharmacy
Memorial Hermann-Texas Medical Center
Houston, Texas
Mallory T. Mouradjian, Pharm.D., BCCP
Clinical Pharmacy Specialist
Department of Pharmacy
Boston Medical Center
Boston, Massachusetts

Case Series: Mental Health and Pain Management in Patients with CVD

Faculty

Katherine E. Di Palo, Pharm.D., MBA, MS, FAHA, FHFSA, BCACP, BCGP
Senior Director
Transitional Care Excellence
Associate Professor
Department of Medicine
Montefiore medical Center
The University Hospital for Albert Einstein College of Medicine
Bronx, New York

Reviewers

M. Lindsey Hedgepeth Kennedy, Pharm.D., BCPS
Clinical specialist in Psychiatry & Addiction Medicine
UNC Health
Clinical Assistant Professor
Addiction Medicine Program
Department of Psychiatry
UNC School of Medicine
Chapel Hill, North Carolina
Rachel C. Lucas, Pharm.D., BCCP
Clinical Assistant Professor
Department of Pharmacy Practice
Binghamton University School of Pharmacy and Pharmaceutical Sciences
Binghamton, New York

Chapter: Artificial Intelligence in the Management of CVD

Faculty

Kazuhiko Kido, Pharm.D., Ph.D., FCCP, BCPS, BCCP
Clinical Associate Professor
Department of Clinical Pharmacy
West Virginia University School of Pharmacy
Morgantown, West Virginia
James C. Lee, Pharm.D., FCCP, AACC, BCACP
Clinical Pharmacist Practitioner
Michael E. DeBakey VA Medical Center
Houston, TX

Reviewers

Hsiang-Yin Chen, Pharm.D.
Professor and Vice Dean
Department of Clinical Pharmacy
School of Pharmacy
Taipei Medical University
Taipei, Taiwan
Dustin Spencer, Pharm.D., MBA, FCCP, BCCP, BCPS
Clinical Director, Cardiopulmonary Diseases
Cardinal Health
Stafford, Texas
Adrian Wong, Pharm.D., MPH, FCCM, FCCP, BCCCP
Clinical Pharmacy Specialist, Medical ICU
Department of Pharmacy
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Chapter: Statistics Applied to Heart Failure Studies: Win Ratio

Faculty

William L. Baker, Pharm.D., FCCP, FACC, FHFSA
Professor
Department of Pharmacy Practice
University of Connecticut School of Pharmacy
Storrs, Connecticut
Youssef Bessada, Pharm.D., BCPS, BCCP
Assistant Clinical Professor
Department of Pharmacy Practice
University of Connecticut School of Pharmacy
Storrs, Connecticut
Katelyn Galli, Pharm.D., BCCP
Clinical Assistant Professor
Department of Pharmacy Practice
University of Connecticut School of Pharmacy
Storrs, Connecticut

Reviewers

Catherine G. Derington, Pharm.D., MS, BCACP
Assistant Professor
Department of Medicine, Division of Cardiology
University of Colorado School of Medicine, Anschutz Medical Campus
Aurora, Colorado
Brian A. Lopez, Pharm.D., BCCP, BCCCP
Clinical Pharmacist
Department of Pharmacy
New London Hospital
New London, New Hampshire
Carol Heunisch, Pharm.D., BCPS, BCCP
Director, Drug Policy and Education
Department of Pharmacy
Endeavor Health
Evanston, Illinois

Chapter: Glucagon-Like Peptide-1 Receptor Agonists in CVD and HFpEF

Faculty

Anne Rodino, Pharm.D., BCCP
Cardiology Clinical Pharmacist Practitioner
Department of Pharmacy
UNC Hospitals and Clinics
Chapel Hill, North Carolina
Holly McIlvain, Pharm.D., BCACP, CSP
Consultant
Visante
Chicago, Illinois

Reviewers

Sheila L. Stadler, Pharm.D., FCCP, BCPS, CLS
Clinical Pharmacy Specialist
Clinical Pharmacy Cardiac Risk Service
Kaiser Permanente Colorado
Aurora, Colorado
Elizabeth Tesch, Pharm.D., BCPS, BCCP
Pharmacy Flight Commander
42d Healthcare Operations Squadron
United States Air Force
Maxwell Air Force Base, Alabama
Emily McElhaney, Pharm.D., BCCP
Cardiology Clinical Pharmacy Specialist
Department of Pharmacy
Cleveland Clinic
Cleveland, Ohio

Chapter: Continuous-Flow Left Ventricular Assist Device

Faculty

Erika M. Schoenborn, Pharm.D., BCCP
Clinical Pharmacist Practitioner
Department of Pharmacy
East Carolina University Health
Greenville, North Carolina

Reviewers

Edward T. Horn, Pharm.D., FCCP
Associate Professor
Department of Pharmacy and Therapeutics
University of Pittsburgh School of Pharmacy
Pittsburgh, Pennsylvania
Lauren Kunkel, Pharm.D., BCCP
Cardiology Clinical Pharmacy Specialist
Department of Pharmacy
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
Julie Clarkson, Pharm.D., BCCCP, BCCP, BCPS
Assistant Professor
University of Pittsburgh School of Pharmacy
Clinical Pharmacist, Advanced Heart Failure and Pulmonary Hypertension
UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania

Case Series: Cardiovascular-Kidney-Metabolic Health

Faculty

Rebecca JC Tran, Pharm.D., BCPS, BCACP, BCCP, CLS
Associate Professor
Department of Pharmacy Practice and Administration
Western University of Health Sciences College of Pharmacy
Pomona, California
Sheryl L. Chow, Pharm.D., FCCP, FAHA, FHFSA
Professor
Department of Pharmacy Practice and Administration
Western University of Health Sciences College of Pharmacy
Pomona, California

Reviewers

Robert L. Page, II, Pharm.D., MSPH, FCCP, FASHP, FASCP, FAHA, FHFSA, BCPS
Professor
Departments of Clinical Pharmacy, Medicine, and Physical Medicine
University of Colorado
Aurora, Colorado
Lavinia Salama, Pharm.D., BCACP, BCGP, BC-ADM, CDCES
Assistant Professor of Pharmacy Practice
Long Island University
Arnold & Marie Schwartz College of Pharmacy and Health Sciences
Brooklyn, New York
Kathy Tang, Pharm.D., BCCP
Clinical Pharmacy Specialist, Cardiology
Department of Pharmacy
Wellstar Kennestone Regional Medical Center
Marietta, Georgia

Chapter: Iron Deficiency in Heart Failure

Faculty

Sarah Wood, Pharm.D.
Cardiology Clinical Pharmacist
Department of Pharmacy
Atrium Health Carolinas Medical Center
Charlotte, North Carolina
Stormi Gale, Pharm.D., FCCP, BCPS, BCCP
Cardiology Pharmacy Coordinator
Department of Pharmacy
Atrium Health Carolinas Medical Center
Charlotte, North Carolina

Reviewers

John E. MacKay, Pharm.D.
Clinical Pharmacy Specialist, Advanced Heart Failure and Heart Transplant
Department of Pharmacy
Providence Heart Institute of Oregon
Providence St. Vincent Medical Center
Portland, Oregon
Melanie R. Madorsky, Pharm.D., BCCCP, BCCP, BCPS
Clinical Pharmacy Specialist, Cardiac Care Unit
Department of Pharmacy
Memorial Hermann-Texas Medical Center
Houston, Texas
Mallory T. Mouradjian, Pharm.D., BCCP
Clinical Pharmacy Specialist
Department of Pharmacy
Boston Medical Center
Boston, Massachusetts

Chapter: Microvascular CVD/MINOCA/ANOCA

Faculty

Charles H. Hayes, III, Pharm.D., FACC, BCCP
Cardiology Clinical Pharmacist
Department of Pharmacy
Saint Luke’s Hospital of Kansas City
Kansas City, Missouri
John Dechand, Pharm.D., BCCP
Cardiovascular Clinical Pharmacist
Team Lead – Cardiovascular Medicine Pharmacists
Department of Pharmacy Services
University of Utah Health
Salt Lake City, Utah

Reviewers

Steven P. Dunn, Pharm.D., FAHA, FCCP, BCCP
Lead Pharmacist, Heart & Vascular
University of Virginia
Charlottesville, Virginia
Jordan L. Lacoste, Pharm.D., FACC, BCCP
Clinical Pharmacy Specialist
Department of Pharmacy
WVU Medicine
Morgantown, West Virginia
Matthew Rockhold, Pharm.D., BCCP
Cardiac Surgery Pharmacist
Department of Pharmacy
West Virginia University Medicine
Morgantown, West Virginia

Chapter: Cardiac Sarcoidosis

Faculty

Megan Clarke, Pharm.D., BCCP
Clinical Pharmacist Practitioner - Cardiology
Department of Cardiology
Novant Health Heart & Vascular Institute
Wilmington, North Carolina
Adele L. Rawls, Pharm.D., BCPS
Assistant Professor for Pharmacology
Edward Via College of Osteopathic Medicine
Spartanburg, South Carolina

Reviewers

James C. Coons, Pharm.D., FCCP, FACC, BCCP
Professor
Department of Pharmacy and Therapeutics
University of Pittsburgh
Clinical Pharmacist, Cardiology
UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania
Kristen de Almeida, MSc, Pharm.D., BCCP, HF-CERT
Cardiology Pharmacy Coordinator
Advanced Heart failure Specialist
Baptist Hospital of Miami
Miami, Florida
Sabrina Dunham, Pharm.D., BCCP, BCPS
Clinical Pharmacist Specialist – Cardiovascular Critical Care
Department of Pharmacy Services
University of Michigan Health
Ann Arbor, Michigan

Chapter: Transthyretin-Related Amyloidosis

Faculty

Lauren Kemp, Pharm.D., BCCP, BCPS, CPP
Clinical Pharmacist
Advanced Heart Failure Clinic
Cone Health/Moses H. Cone Memorial Hospital
Greensboro, North Carolina
Arwa Omary, Pharm.D., BCCP
Cardiology Clinical Pharmacy Specialist
Intensive Care Unit
Prairie Mountain Health
Manitoba, Canada

Reviewers

Kathleen Faulkenberg, Pharm.D., FHFSA, BCCP
Associate Director of Cardiology, Transplant, and Transitions of Care
Department of Pharmacy
University of Kentucky Healthcare
Lexington, Kentucky
Amy Hathorn, Pharm.D., BCCP
Clinical Pharmacist Specialist
Department of Pharmacy
Atrium Health
Charlotte, North Carolina
Tomasz Jurga, Pharm.D., BCPS, BCACP, BCCP, CDCES
Clinical Pharmacist Practitioner, Cardiology
Department of Pharmacy
Lieutenant Colonel Charles S. Kettles VA Medical Center
Ann Arbor, Michigan

Chapter: Statistics Applied to Heart Failure Studies: Win Ratio

Faculty

William L. Baker, Pharm.D., FCCP, FACC, FHFSA
Professor
Department of Pharmacy Practice
University of Connecticut School of Pharmacy
Storrs, Connecticut
Youssef Bessada, Pharm.D., BCPS, BCCP
Assistant Clinical Professor
Department of Pharmacy Practice
University of Connecticut School of Pharmacy
Storrs, Connecticut
Katelyn Galli, Pharm.D., BCCP
Clinical Assistant Professor
Department of Pharmacy Practice
University of Connecticut School of Pharmacy
Storrs, Connecticut

Reviewers

Catherine G. Derington, Pharm.D., MS, BCACP
Assistant Professor
Department of Medicine, Division of Cardiology
University of Colorado School of Medicine, Anschutz Medical Campus
Aurora, Colorado
Brian A. Lopez, Pharm.D., BCCP, BCCCP
Clinical Pharmacist
Department of Pharmacy
New London Hospital
New London, New Hampshire
Carol Heunisch, Pharm.D., BCPS, BCCP
Director, Drug Policy and Education
Department of Pharmacy
Endeavor Health
Evanston, Illinois

CPE Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are approved by BPS as a provider for the recertification of BCCP.

BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/

To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.

The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.

In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.

The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.

Target Audience: The target audience for Cardiology Self-Assessment Program (CardSAP) 2025 is board-certified cardiology pharmacy specialists and advanced practitioners specializing in cardiovascular care.

Contents

Chapter: Transthyretin-Related Amyloidosis

Activity Number: 0217-9999-25-225-H01-P
Contact Hour(s): 3.00
Activity Type: Application Based
Learning Objectives

1. Distinguish between the two main types of cardiac amyloidosis (CA)—monoclonal immunoglobulin light chain (AL) amyloidosis and transthyretin-related amyloidosis (ATTR)—and account for the differences in prognosis and treatment.

2. Evaluate patients for the presentation of classic clinical features of CA, including cardiac and extracardiac manifestations.

3. Apply features of a diagnostic algorithm to distinguish between different etiologies of CA, and correctly diagnose a patient with ATTR.

4. Develop pharmacotherapy for a patient with ATTR cardiomyopathy (ATTR-CM) that addresses best supportive care, heart failure (HF) treatment, and other treatment of important comorbidities.

5. Evaluate the appropriate use and place of therapy of emerging therapies for a patient with ATTR-CM.

6. Assess the economic burden of the treatment of ATTR-CM disease-modifying therapies on both the patient and the health care system.

Chapter: Iron Deficiency in Heart Failure

Activity Number: 0217-9999-25-226-H01-P
Contact Hour(s): 2.50
Activity Type: Application Based
Learning Objectives

1. Evaluate the rationale and recommendations for iron replacement in patients who have iron deficiency in heart failure (IDHF) with and without anemia.

2. Assess the limitations of the current diagnostic criteria for IDHF.

3. Distinguish the clinical evidence and differences in logistical considerations among available intravenous iron formulations.

4. Design an appropriate intravenous iron replacement regimen for a patient with IDHF accounting for the challenges and practical considerations in both inpatient and outpatient settings.

5. Investigate evidence for intravenous iron administration in understudied populations with HF and explore future directions.

Chapter: Continuous-Flow Left Ventricular Assist Device

Activity Number: 0217-9999-25-227-H01-P
Contact Hour(s): 2.00
Activity Type: Application Based
Learning Objectives

1. Evaluate the role of guideline-directed medical therapy (GDMT) for myocardial recovery in patients with continuous-flow left ventricular assist device (CF-LVADs) according to recent guideline updates.

2. Construct a pharmacotherapy plan for patients immediately before and after CF-LVAD implantation.

3. Design an appropriate pharmacotherapeutic regimen in stable patients with CF-LVADs.

4. Analyze available literature to determine the role of GDMT in the management of complications after CF-LVAD implantation.

Chapter: Cardiac Sarcoidosis

Activity Number: 0217-9999-25-228-H01-P
Contact Hour(s): 1.50
Activity Type: Application Based
Learning Objectives

1. Apply knowledge of the pathophysiology of cardiac sarcoidosis (CS).

2. Distinguish characteristics of patients with CS.

3. Evaluate patients for the presence of diagnostic criteria for CS.

4. Develop a treatment plan, including immunosuppression, rhythm control, and advanced therapies, for patients with CS.

5. Assess the effect of clinical manifestations on clinical outcomes in a patient with CS.

Chapter: Glucagon-Like Peptide-1 Receptor Agonists in CVD and HFpEF

Activity Number: 0217-9999-25-229-H01-P
Contact Hour(s): 2.00
Activity Type: Application Based
Learning Objectives

1. Analyze the pharmacology of incretin-based therapies and mechanisms of cardiovascular (CV) benefit.

2. Evaluate published data to support the use of glucagon-like peptide-1 receptor antagonists (GLP-1 RAs) for CV risk reduction in patients with and at risk of CV disease.

3. Distinguish medical, economic, and psychosocial barriers to GLP-1 RA prescribing.

4. Design an appropriate workup for a patient presenting with heart failure with preserved ejection fraction (HFpEF).

5. Develop an appropriate evidence-based regimen for the pharmacologic treatment of a patient with HFpEF.

Chapter: Microvascular CVD/MINOCA/ANOCA

Activity Number: 0217-9999-25-230-H01-P
Contact Hour(s): 2.50
Activity Type: Application Based
Learning Objectives

1. Distinguish the differences in terminology and definitions between angina with nonobstructive coronary arteries (ANOCA) and myocardial infarction with nonobstructive coronary arteries (MINOCA) based on available guidelines and consensus statements.

2. Demonstrate an understanding of the diagnostic modalities and testing results used for patients with suspected ANOCA.

3. Design a treatment plan for patients with each of the currently identified endotypes of ANOCA.

4. Apply appropriate steps necessary in the clinical evaluation of suspected MINOCA.

5. Evaluate the current secondary prevention strategies in MINOCA and their expected effects on cardiovascular outcomes.

Case Series: Mental Health and Pain Management in Patients with CVD

Activity Number: 0217-9999-25-231-H01-P
Contact Hour(s): 2.00
Activity Type: Application Based
Learning Objectives

1. Evaluate the complex interactions between mental health disorders, chronic pain, and cardiovascular disease and their impact on outcomes

2. Design patient-centered, safe, and effective pharmacotherapy for managing mental health disorders and chronic pain in cardiovascular disease

3. Integrate nonpharmacologic approaches as components of a comprehensive pain and mental health management plan tailored to patients with cardiovascular disease.

4. Evaluate the role of palliative pharmacotherapy in end-stage cardiovascular disease to prioritize patient comfort and symptom relief.

Case Series: Cardiovascular-Kidney-Metabolic Health

Activity Number: 0217-9999-25-232-H01-P
Contact Hour(s): 2.00
Activity Type: Application Based
Learning Objectives

1. Distinguish stages of the new cardiovascular-kidney-metabolic (CKM) syndrome.

2. Evaluate the biological risk factors and social determinants of health contributing to the development of CKM syndrome.

3. Evaluate a patient’s risk for cardiovascular disease (CVD) with the new PREVENT risk calculator.

4. Given a patient case, devise a strategy to prevent the development or slow the progression of CKM syndrome.

5. Develop treatment recommendations for the patient with CVD and CKM syndrome.

Chapter: Artificial Intelligence in the Management of CVD

Activity Number: 0217-9999-25-233-H01-P
Contact Hour(s): 1.50
Activity Type: Application Based
Learning Objectives

1. Evaluate potential applications of artificial intelligence (AI) use in cardiovascular (CV) diseases.

2. Apply contemporary AI/machine learning (ML) prediction models to patients receiving high-risk medications with CV implications.

3. Design an AI-based remote monitoring plan for patients with CV diseases.

4. Apply key concepts of phenomapping/clustering techniques to pharmacy practice.

5. Demonstrate potential challenges of AI-based algorithms and prediction models.

6. Justify potential clinical implications of AI in the future practice of CV pharmacists.

Chapter: Statistics Applied to Heart Failure Studies: Win Ratio

Activity Number: 0217-9999-25-234-H01-P
Contact Hour(s): 1.50
Activity Type: Application Based
Learning Objectives

1. Distinguish the differences between the conventional approaches to analyzing heart failure (HF) trial outcomes and the win ratio (WR).

2. Assess the differences in findings from HF trials reanalyzed using WR.

3. Analyze the design and findings of contemporary HF trials using WR.

4. Assess the strengths and weaknesses of WR use in HF trials and how clinicians should interpret and apply the findings.

Disclosures


Commercial Support

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.